Mark McCamish

6.3k total citations · 2 hit papers
33 papers, 4.6k citations indexed

About

Mark McCamish is a scholar working on Nutrition and Dietetics, Physiology and Immunology. According to data from OpenAlex, Mark McCamish has authored 33 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nutrition and Dietetics, 9 papers in Physiology and 8 papers in Immunology. Recurrent topics in Mark McCamish's work include Clinical Nutrition and Gastroenterology (7 papers), Biosimilars and Bioanalytical Methods (7 papers) and Regulation of Appetite and Obesity (6 papers). Mark McCamish is often cited by papers focused on Clinical Nutrition and Gastroenterology (7 papers), Biosimilars and Bioanalytical Methods (7 papers) and Regulation of Appetite and Obesity (6 papers). Mark McCamish collaborates with scholars based in United States, Netherlands and United Kingdom. Mark McCamish's co-authors include Elizabeth Lawrence, Gill Langmack, Susan A. Jebb, Andrew M. Prentice, I. Sadaf Farooqi, Ieuan A. Hughes, Stephen O’Rahilly, Gillian R. Woollett, Robert F. Kushner and Russell M. Dixon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Mark McCamish

32 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency

1999 1.4k citations I. Sadaf Farooqi, Susan A. Jebb et al. New England Journal of Medicine profile →
Recombinant Leptin for Weight Loss in Obese and Lean Adults

1999 1.0k citations Steven B. Heymsfield, Andrew S. Greenberg et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark McCamish United States	22	2.1k	2.0k	1.6k	1.0k	429	33	4.6k
Louise Nordfors Sweden	29	827 0.4×	1.1k 0.6×	520 0.3×	1.1k 1.1×	429 1.0×	67	3.6k
Gianfranco Guarnieri Italy	34	736 0.4×	1.5k 0.7×	588 0.4×	498 0.5×	323 0.8×	85	3.1k
Troels Krarup Hansen Denmark	40	1.1k 0.5×	1.3k 0.6×	719 0.4×	897 0.9×	900 2.1×	154	5.5k
Jonathan Pinkney United Kingdom	33	974 0.5×	1.9k 1.0×	568 0.4×	1.1k 1.1×	802 1.9×	109	5.0k
Nikos Yiannakouris Greece	28	1.1k 0.5×	1.5k 0.7×	515 0.3×	1.4k 1.3×	319 0.7×	67	3.4k
Nicola Santoro United States	42	584 0.3×	1.5k 0.8×	536 0.3×	2.2k 2.1×	967 2.3×	130	5.7k
Susanne Kaser Austria	37	410 0.2×	1.3k 0.6×	256 0.2×	2.2k 2.1×	849 2.0×	104	4.8k
Piotr Ceranowicz Poland	33	687 0.3×	487 0.2×	514 0.3×	541 0.5×	1.5k 3.5×	143	3.2k
Kazuhisa Maeda Japan	9	893 0.4×	2.0k 1.0×	180 0.1×	3.1k 3.0×	276 0.6×	24	4.3k
Tomohiro Katsuya Japan	44	303 0.1×	1.2k 0.6×	437 0.3×	986 1.0×	671 1.6×	171	6.8k

Countries citing papers authored by Mark McCamish

Since Specialization

Citations

This map shows the geographic impact of Mark McCamish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McCamish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McCamish more than expected).

Fields of papers citing papers by Mark McCamish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark McCamish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McCamish. The network helps show where Mark McCamish may publish in the future.

Co-authorship network of co-authors of Mark McCamish

This figure shows the co-authorship network connecting the top 25 collaborators of Mark McCamish. A scholar is included among the top collaborators of Mark McCamish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark McCamish. Mark McCamish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takimoto, Chris H., Mark P. Chao, C. Parker Gibbs, et al.. (2019). The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target. Annals of Oncology. 30(3). 486–489. 90 indexed citations

McCamish, Mark & Gillian R. Woollett. (2013). The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary?. Clinical Pharmacology & Therapeutics. 93(4). 315–317. 34 indexed citations

McCamish, Mark & Gillian R. Woollett. (2012). The State of the Art in the Development of Biosimilars. Clinical Pharmacology & Therapeutics. 91(3). 405–417. 120 indexed citations

McCamish, Mark & Gillian R. Woollett. (2011). Worldwide experience with biosimilar development. mAbs. 3(2). 209–217. 150 indexed citations

Mittendorfer, Bettina, Jeffrey F. Horowitz, Alex M. DePaoli, et al.. (2011). Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes. Diabetes. 60(5). 1474–1477. 88 indexed citations

McCamish, Mark & Raquel Izumi. (2006). Perspectives on Development of a Combination Pharmacogenomic Diagnostic and Drug Product. Pharmacogenomics. 7(7). 1045–1049. 4 indexed citations

Zelissen, Pierre, Kaj Stenlöf, Michael E. J. Lean, et al.. (2005). Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo‐controlled trial. Diabetes Obesity and Metabolism. 7(6). 755–761. 111 indexed citations

Artz, Andrew, Dean Fergusson, Paul J. Drinka, et al.. (2004). Mechanisms of Unexplained Anemia in the Nursing Home. Journal of the American Geriatrics Society. 52(3). 423–427. 80 indexed citations

Nordyke, Robert J., et al.. (2004). Impact of Anemia on Hospitalization Time, Charges, and Mortality in Patients with Heart Failure. Value in Health. 7(4). 464–471. 35 indexed citations

10.

Artz, Andrew, Dean Fergusson, Paul J. Drinka, et al.. (2004). Prevalence of anemia in skilled-nursing home residents. Archives of Gerontology and Geriatrics. 39(3). 201–206. 64 indexed citations

11.

Frölich, Marijke, et al.. (2003). The decline in plasma leptin in response to calorie restriction predicts the effects of adjunctive leptin treatment on body weight in humans. European Journal of Internal Medicine. 14(7). 415–418. 11 indexed citations

12.

Tappy, Luc, Mette M. Berger, Jean‐Marc Schwarz, et al.. (1999). Hepatic and Peripheral Glucose Metabolism in Intensive Care Patients Receiving Continuous High‐ or Low‐Carbohydrate Enteral Nutrition. Journal of Parenteral and Enteral Nutrition. 23(5). 260–268. 31 indexed citations

13.

Heymsfield, Steven B., Andrew S. Greenberg, Ken Fujioka, et al.. (1999). Recombinant Leptin for Weight Loss in Obese and Lean Adults. JAMA. 282(16). 1568–1568. 1041 indexed citations breakdown →

14.

Farooqi, I. Sadaf, Susan A. Jebb, Gill Langmack, et al.. (1999). Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency. New England Journal of Medicine. 341(12). 879–884. 1411 indexed citations breakdown →

15.

Houdijk, Alexander P. J., J. Jansen, R.I.C. Wesdorp, et al.. (1998). Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. The Lancet. 352(9130). 772–776. 452 indexed citations

16.

Zhao, Xiaotuan, Mark McCamish, Robert H. Miller, Lijie Wang, & Henry C. Lin. (1997). Intestinal Transit and Absorption of Soy Protein In Dogs Depend On Load and Degree of Protein Hydrolysis. Journal of Nutrition. 127(12). 2350–2356. 42 indexed citations

17.

Gallagher‐Allred, Charlette R., Anne Coble Voss, Susan Calvert Finn, & Mark McCamish. (1996). Malnutrition and Clinical Outcomes. Journal of the American Dietetic Association. 96(4). 361–369. 182 indexed citations

18.

McCamish, Mark, et al.. (1995). Amino Acid Losses During Hemodialysis: Effects of High‐Solute Flux and Parenteral Nutrition in Acute Renal Failure. Journal of Parenteral and Enteral Nutrition. 19(1). 15–21. 26 indexed citations

19.

Chlebowski, R. T., et al.. (1994). Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial.. PubMed. 9(6). 507–12. 53 indexed citations

20.

McCamish, Mark. (1994). Enteral and Parenteral Nutrition Support of Terminally Ill Patients. The Hospice Journal. 9(2/3). 107–129. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact